
See exactly how TSPA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TSPA and 80,000+ other tickers.
TSPA invests in US-listed companies in an attempt to provide exposure similar to its benchmark, the S&P 500 an index composed of the 500 largest publicly traded US firms. The fund aims to be sector neutral by weighting each industry close to the index, while seeking to outperform it by overweighting or underweighting individual holdings based on fundamental research, which measures how favorable each stock is. Unlike other ETFs that publish full portfolio holdings daily, TSPA publishes a proxy portfolio on its website. The proxy portfolio is a basket of securities designed to closely track…

T. Rowe Price Group launched three active equity ETFs Thursday. The funds target biotechnology, small-cap and mid-cap stocks, the company said.

Integrated Wealth Concepts LLC lifted its position in T. Rowe Price U.S. Equity Research ETF (NYSEARCA:TSPA) by 633.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 71,566 shares of the company's stock after purchasing an additional 61,815

Investors are used to a swirling mass of scary headlines and geopolitical and monetary risk. Yen carry trade and yield concerns, however, may have some feeling of trepidation.

Active ETFs continue to gather market share at a rapid pace in 2026 with derivative income ETFs a key driver. Data through July shows total active ETF net inflows reached $457 billion.

Balefire LLC purchased a new stake in shares of T. Rowe Price U.S. Equity Research ETF (NYSEARCA:TSPA) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 18,365 shares of the company's stock, valued at approximately $873,000. Several other institutional investors also